Mrs Tanya Muresan
European Hospital Georges Pompidou, Paris (France)
Estimation of the target population of a selective cardiac myosin inhibitor for hypertrophic obstructive cardiomyopathy: Real-life data from the French REMY register.
Event: Heart Failure 2023
Topic: Hypertrophic Cardiomyopathy
Session: Myocardial disease - hypertrophic cardiomyopathy 3
